Application Nr Approved Date Route Status External Links
NDA209803 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Steglatro™ Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Steglatro Is A Sodium Glucose Co-Transporter 2 (Sglt2) Inhibitor Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1 ) Limitations Of Use: Not For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. ( 1 ) Limitations Of Use Steglatro Is Not Recommended In Patients With Type 1 Diabetes Mellitus Or For The Treatment Of Diabetic Ketoacidosis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ertugliflozin Pidolate

Comments